Related Experiment Video
Updated: Jan 16, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
792
Therapeutic Effect of Micro-Energy Treatment for Erectile Dysfunction: A Systematic Review and Meta-Analysis Based on
Hao Li1, Wenchao Xu1, Tao Wang1
1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The World Journal of Men'S Health
|October 5, 2025
Summary
Micro-energy treatment (MET) effectively improves erectile dysfunction (ED) for up to a year, particularly for vasculogenic ED. Optimal protocols involve twice-weekly sessions, and combining MET with other therapies enhances results.
Area of Science:
- Urology
- Regenerative Medicine
- Medical Technology
Background:
- Erectile dysfunction (ED) is a prevalent condition affecting millions of men.
- Micro-energy treatment (MET) is an emerging therapeutic option for ED.
- MET encompasses low-intensity extracorporeal shockwave therapy, low-intensity pulsed ultrasound, and electromagnetic fields.
Purpose of the Study:
- To assess the therapeutic efficacy of micro-energy treatment (MET) for erectile dysfunction (ED).
- To identify optimal treatment parameters for MET in managing ED.
- To summarize the current literature on MET for ED.
Main Methods:
- A systematic literature search was conducted across PubMed, Web of Science, and Embase.
- Included 32 randomized controlled trials involving 1,986 patients with ED.
- Evaluated therapeutic effects using the International Index of Erectile Function and Erection Hardness Score, with subgroup analyses on various parameters.
Main Results:
- MET significantly improved erectile function compared to controls at 1, 3, 6, and 12 months post-treatment.
- Treatment twice weekly was more effective than once weekly (p<0.05).
- Vasculogenic ED showed better response than neurogenic ED (p<0.05); combination therapy enhanced efficacy (p<0.05).
Conclusions:
- Micro-energy treatment (MET) is effective for various ED types, with sustained efficacy up to one year.
- Optimal therapeutic protocol involves twice-weekly sessions for no more than 4 weeks.
- Combining MET with other therapies yields synergistic effects for ED management.
Keywords:
Electromagnetic fieldsErectile dysfunctionExtracorporeal shockwave therapyPhosphodiesterase 5 InhibitorsUltrasonic wavesMore Related Videos
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
557
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
557
01:30Electroconvulsive Therapy
891
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
891